News Conference News EuroPCR 2016 Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices Michael O'Riordan May 23, 2016
News Conference News EuroPCR 2016 Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You? Yael L. Maxwell May 20, 2016
News Conference News EuroPCR 2016 LAA Closure May Provide Solution for Stroke Prevention in Patients With Prior Intracerebral Hemorrhage Yael L. Maxwell May 18, 2016
News Conference News EuroPCR 2016 Of Hands and Hearts: Upper-Extremity Dysfunction Common Early After Transradial PCI Michael O'Riordan May 18, 2016
News Conference News EuroPCR 2016 EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy Yael L. Maxwell May 17, 2016
News Conference News EuroPCR 2016 ‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices Caitlin E. Cox May 17, 2016
News Conference News EuroPCR 2016 EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’ Shelley Wood May 16, 2016
News Conference News EuroPCR 2015 Trials Explore the Potential of Biodegradable-Polymer Stents Caitlin E. Cox May 21, 2015
News Conference News EuroPCR 2015 Sapien 3 Experience in Europe, Canada Shows Low Mortality, Paravalvular Leak at 30 Days Yael L. Maxwell May 21, 2015
News Conference News EuroPCR 2015 PRAGUE-13 Finds No Advantage to Complete Revascularization After Primary PCI Caitlin E. Cox May 19, 2015
News Conference News EuroPCR 2015 NOTION: 2-Year Data Show Positive Outlook for TAVR in Lower-Risk Patients Yael L. Maxwell May 19, 2015